OLEG KHAYKIN, the President & CEO of $VIAV, sold 40,238 shares of the company on 12-05-2025 for an estimated $704,165. We received data on the trade from a recent SEC filing. This was a sale of approximately 50.0% of their shares of this class of stock. Following this trade, they now own 40,238 shares of this class of $VIAV stock.
$VIAV Insider Trading Activity
$VIAV insiders have traded $VIAV stock on the open market 28 times in the past 6 months. Of those trades, 0 have been purchases and 28 have been sales.
Here’s a breakdown of recent trading of $VIAV stock by insiders over the last 6 months:
- OLEG KHAYKIN (President & CEO) has made 0 purchases and 7 sales selling 268,326 shares for an estimated $4,715,119.
- KEITH BARNES has made 0 purchases and 4 sales selling 175,400 shares for an estimated $3,139,797.
- ILAN DASKAL (EVP, CFO) has made 0 purchases and 3 sales selling 170,000 shares for an estimated $2,972,993.
- DONALD A COLVIN has made 0 purchases and 2 sales selling 40,000 shares for an estimated $683,607.
- KEVIN CHRISTOPHER SIEBERT (SVP Gen. Counsel & Secretary) has made 0 purchases and 3 sales selling 34,190 shares for an estimated $460,186.
- LUKE M SCRIVANICH (SVP General Manager OSP) has made 0 purchases and 3 sales selling 30,625 shares for an estimated $412,511.
- RICHARD BELLUZZO has made 0 purchases and 4 sales selling 33,542 shares for an estimated $366,533.
- PAUL MCNAB (EVP, Chief Mktg & Stgy Officer) has made 0 purchases and 2 sales selling 14,274 shares for an estimated $249,719.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VIAV Hedge Fund Activity
We have seen 182 institutional investors add shares of $VIAV stock to their portfolio, and 175 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 5,389,435 shares (+431.1%) to their portfolio in Q3 2025, for an estimated $68,391,930
- WOODLINE PARTNERS LP removed 5,308,328 shares (-51.5%) from their portfolio in Q3 2025, for an estimated $67,362,682
- POINT72 ASSET MANAGEMENT, L.P. added 4,082,782 shares (+inf%) to their portfolio in Q3 2025, for an estimated $51,810,503
- ALYESKA INVESTMENT GROUP, L.P. removed 3,952,364 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $50,155,499
- WELLINGTON MANAGEMENT GROUP LLP removed 3,717,624 shares (-20.5%) from their portfolio in Q3 2025, for an estimated $47,176,648
- WESTWOOD HOLDINGS GROUP INC removed 3,292,976 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $33,160,268
- NEUBERGER BERMAN GROUP LLC removed 2,432,130 shares (-92.3%) from their portfolio in Q3 2025, for an estimated $30,863,729
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$VIAV Revenue
$VIAV had revenues of $299.1M in Q1 2026. This is an increase of 25.57% from the same period in the prior year.
You can track VIAV financials on Quiver Quantitative's VIAV stock page.
$VIAV Analyst Ratings
Wall Street analysts have issued reports on $VIAV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 10/13/2025
- Morgan Stanley issued a "Underweight" rating on 08/11/2025
- Rosenblatt issued a "Buy" rating on 06/20/2025
To track analyst ratings and price targets for $VIAV, check out Quiver Quantitative's $VIAV forecast page.
$VIAV Price Targets
Multiple analysts have issued price targets for $VIAV recently. We have seen 7 analysts offer price targets for $VIAV in the last 6 months, with a median target of $17.0.
Here are some recent targets:
- Jim Kelleher from Argus Research set a target price of $23.0 on 11/05/2025
- Ryan Koontz from Needham set a target price of $20.0 on 10/30/2025
- Mike Genovese from Rosenblatt set a target price of $19.0 on 10/30/2025
- Andrew Spinola from UBS set a target price of $17.0 on 10/30/2025
- Ruben Roy from Stifel set a target price of $15.0 on 10/13/2025
- Meta Marshall from Morgan Stanley set a target price of $9.3 on 08/11/2025
- Dave Kang from B. Riley Securities set a target price of $12.0 on 08/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
